How to Register

Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)

International Journal of Clinical Oncology Volume 27 Page 112-120 published_at 2021-10-13

アクセス数 : 1669 件

ダウンロード数 : 62 件

今月のアクセス数 : 58 件

今月のダウンロード数 : 2 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/54701

File	Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B) 1000 KB エンバーゴ : 2023-03-13
Title	Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)
Creator	Tsubata Yukari Watanabe Kana Saito Ryota Nakamura Atsushi Yoshioka Hiroshige Morita Mami Honda Ryoichi Kanaji Nobuhiro Ohizumi Satoshi Jingu Daisuke Nakagawa Taku Nakazawa Kensuke Mouri Atsuto Takeuchi Susumu Furuya Naoki Akazawa Yuki Miura Kiyotaka Ichihara Eiki Maemondo Makoto Morita Satoshi Kobayashi Kunihiko Isobe Takeshi
Source Title	International Journal of Clinical Oncology
Volume	27
Start Page	112
End Page	120
Journal Identifire	ISSN 1341-9625 EISSN 1437-7772
Language	eng
Resource Type	journal article
Publisher	Japan Society of Clinical Oncology
Date of Issued	2021-10-13
Publish Type	Accepted Manuscript
Access Rights	open access
Relation	[DOI] 10.1007/s10147-021-02043-2 [PMID] 34643820